Literature DB >> 15389594

Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site.

Samuel Varghese1, Sheila Rydziel, Ernesto Canalis.   

Abstract

Transforming growth factor-beta (TGFbeta) superfamily of growth factors, which include bone morphogenetic proteins (BMPs), have multiple effects in osteoblasts. In this study, we examined the regulation of collagenase-3 promoter activity by BMP-2 in osteoblast-enriched (Ob) cells from fetal rat calvariae. BMP-2 suppressed the activity of a -2 kb collagenase-3 promoter/luciferase recombinant in a time- and dose-dependent manner. The BMP-2 effect on the collagenase-3 promoter was further tested in several collagenase-3 promoter deletion constructs and it was narrowed down to a -148 to -94 nucleotide segment of the promoter containing a runt domain factor 2 (Runx2) site at nucleotide -132 to -126. The effect of BMP-2 was obliterated in a collagenase-3 promoter/luciferase construct containing a mutated Runx2 (mRunx2) sequence indicating that the Runx2 site mediates the BMP-2 response. Electrophoretic mobility shift assays, using nuclear extracts from control and BMP-2-treated Ob cells, indicated that the Runx2 protein is a component of the specific DNA-protein complex formed on the Runx2 site and that the BMP-2 effect may be associated with minor protein modifications rather than major changes in the composition of specific proteins interacting with the Runx2 site. We confirmed that other members of the TGFbeta family can down-regulate the collagenase-3 promoter by showing that TGFbeta1 also suppresses the promoter activity in a time- and dose-dependent manner. In conclusion, this study demonstrates that BMP-2 and TGFbeta1 suppress collagenase-3 promoter activity in osteoblasts and establishes a link between BMP-2 action and collagenase-3 expression via Runx2, a major regulator of osteoblast formation and function. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389594     DOI: 10.1002/jcp.20130

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Dysregulation of chondrogenesis in human cleidocranial dysplasia.

Authors:  Qiping Zheng; Eiman Sebald; Guang Zhou; Yuqing Chen; William Wilcox; Brendan Lee; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2005-06-10       Impact factor: 11.025

2.  Divergent upstream osteogenic events contribute to the differential modulation of MG63 cell osteoblast differentiation by MMP-1 (collagenase-1) and MMP-13 (collagenase-3).

Authors:  Takayuki Hayami; Yvonne L Kapila; Sunil Kapila
Journal:  Matrix Biol       Date:  2011-04-22       Impact factor: 11.583

3.  RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Authors:  Yalin Li; Wei Pan; Wanfeng Xu; Nan He; Xuewu Chen; Hong Liu; L Darryl Quarles; Honghao Zhou; Zhousheng Xiao
Journal:  Mutagenesis       Date:  2009-06-10       Impact factor: 3.000

4.  Gamma-synuclein: cell-type-specific promoter activity and binding to transcription factors.

Authors:  Irina Surgucheva; Andrei Surguchov
Journal:  J Mol Neurosci       Date:  2008-05-23       Impact factor: 3.444

5.  Smad1 promotes colorectal cancer cell migration through Ajuba transactivation.

Authors:  Daming Yang; Tieying Hou; Lei Li; Yimin Chu; Fengli Zhou; Ying Xu; Xinyu Hou; Huan Song; Kai Zhu; Zhaoyuan Hou; Haixia Peng; Hao Jia
Journal:  Oncotarget       Date:  2017-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.